Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 1;18(1):267.
doi: 10.1186/s13018-023-03583-1.

The use of liposomal bupivacaine in fracture surgery: a review

Affiliations
Review

The use of liposomal bupivacaine in fracture surgery: a review

Andrew D Gailey et al. J Orthop Surg Res. .

Abstract

Historically, opioids have played a major role in the treatment of postoperative pain in orthopedic surgery. A multitude of adverse events have been associated with opioid use and alternative approaches to pain relief are being investigated, with particular focus on multimodal pain management regimens. Liposomal bupivacaine (EXPAREL) is a component of some multimodal regimens. This formulation of bupivacaine encapsulates the local anesthetic into a multivesicular liposome to theoretically deliver a consistent amount of drug for up to 72 hours. Although the use of liposomal bupivacaine has been studied in many areas of orthopedics, there is little evidence evaluating its use in patients with fractures. This systematic review of the available data identified a total of eight studies evaluating the use of liposomal bupivacaine in patients with fractures. Overall, these studies demonstrated mixed results. Three studies found no difference in postoperative pain scores on postoperative days 1-4, while two studies found significantly lower pain scores on the day of surgery. Three of the studies evaluated the quantity of narcotic consumption postoperatively and failed to find a significant difference between control groups and groups treated with liposomal bupivacaine. Further, significant variability in comparison groups and study designs made interpretation of the available data difficult. Given this lack of clear evidence, there is a need for prospective, randomized clinical trials focused on fully evaluating the use of liposomal bupivacaine in fracture patients. At present, clinicians should maintain a healthy skepticism and rely on their own interpretation of the available data before widely implementing the use of liposomal bupivacaine.

Keywords: EXPAREL; Fracture; Liposomal bupivacaine; Multimodal; Orthopedic surgery; Postoperative pain.

PubMed Disclaimer

Conflict of interest statement

No authors hold any competing interests in a personal or financial nature with regards to this manuscript.

Figures

Fig. 1
Fig. 1
PRISMA diagram demonstrating search, screening, and exclusion processes

Similar articles

Cited by

References

    1. Number of all-listed procedures for discharges from short-stay hospitals, by procedure category and age: United States, 2010. Centers for Disease Control and Prevention. Published online 2010:2.
    1. Brown CA, Starr AZ, Nunley JA. Analysis of Past Secular Trends of Hip Fractures and Predicted Number in the Future 2010–2050 | Ovid. Accessed Sept 9, 2019. https://oce-ovid-com.libproxy.lib.unc.edu/article/00005131-201202000-000.... - PubMed
    1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 | Ovid. J Bone Joint Surg. 2007;89(4):780–785. doi: 10.2106/00004623-200704000-00012. - DOI - PubMed
    1. Soffin EM, Waldman SA, Stack RJ, Liguori GA. An evidence-based approach to the prescription opioid epidemic in orthopedic surgery. Anest Analg. 2017;125(5):1704–1713. doi: 10.1213/ANE.0000000000002433. - DOI - PubMed
    1. Seymour RB, Ring D, Higgins T, Hsu JR. Leading the way to solutions to the opioid epidemic: AOA critical issues. J Bone Joint Surg Am. 2017;99(21):e113. doi: 10.2106/JBJS.17.00066. - DOI - PubMed

MeSH terms

LinkOut - more resources